期刊文献+

妇科恶性肿瘤感染患者血清降钙素原的检测及其临床意义 被引量:4

下载PDF
导出
摘要 目的了解在妇科恶性肿瘤感染患者中检测血清降钙素原的临床意义。方法妇科恶性肿瘤伴发热患者90例,在发热后和退热后留取血标本行降钙素原检测。将细菌培养阳性和抗生素治疗有效的53例作为感染组,细菌培养培养阴性和其它对症处理有效的37例对照组,比较两组患者发热后和退热后血清降钙素原的水平。结果感染组患者发热后的血清降钙素原水平明显高于对照组,且退热后明显降低(P<0.01)。结论血清降钙素原水平与细菌感染关系密切,可用于鉴别诊断妇科恶性肿瘤发热患者是否发生感染。
出处 《广东医学院学报》 2014年第4期469-470,共2页 Journal of Guangdong Medical College
  • 相关文献

参考文献10

  • 1Lippi G, Meschi T, Cervellin G, et al. Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneu- monia: clinical evidence and perspectives[J]. Eur J Intern Med, 2011, 22(5):460-465.
  • 2医院感染诊断标准(试行)[J].中华医学杂志,2001,81(5):314-320. 被引量:5758
  • 3魏欣,曾邦雄,袁世荧.降钙素原——细菌感染全身反应的新指标[J].国外医学(麻醉学与复苏分册),2002,23(2):82-83. 被引量:10
  • 4Pascoe J, Steven N. Antibiotics for the prevention of febrile neutro- penia[J]. Curr Opin Hematol, 2009, 16(1):48-52.
  • 5Dale D C. Colony-stimulating factors for the management of neutro- penia in cancer patients[J]. Drugs, 2002, 62(Suppl 1): 1-15.
  • 6Carnino L, Betteto S, Loiacono M, et al. Procalcitonin as a predictive marker of infections in chemoinduced neutropenia[J]. J Cancer Res Clin Oncol, 2010, 136(4):611-615.
  • 7Toussaint E, Babel-Ball E, Vekemans M, et al. Causes of fever in cancer patients (prospective study over 477 episodes)[J]. Support Care Cancer, 2006, 14(7):763- 769.
  • 8赵小飞,钟景红,黄晓菱.新生儿败血症血清降钙素原和可溶性细胞间黏附分子-1的变化[J].广东医学院学报,2011,29(1):27-28. 被引量:6
  • 9王大明,朱滨,丁良才,张劲松.降钙素原在肾移植术后患者肺部感染诊断中的应用[J].中华急诊医学杂志,2011,20(5):524-527. 被引量:28
  • 10Schuttrumpf S, Binder L, Hagemann T, et al. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients[J]. Ann Hematol, 2003, 82(2):98-103.

二级参考文献36

共引文献5798

同被引文献36

  • 1张代民.降钙素原的测定与临床应用进展[J].实用医药杂志,2007,24(5):619-622. 被引量:57
  • 2Carnino L,Betteto S,Loiacono M,et al. Procalcitonin as a predictive marker of infections in chemoindueed neutrope- nia[J]. J Cancer Res Clin Oncol, 2010,1 36 (4) : 611-615.
  • 3Shomali W, Hachem R,Chaftari AM, et al. Can procalci- tonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients[J]. Cancer, 2012, 118 (23) :5823- 5829.
  • 4National Committee for Clinical Laboratory Standards. EP5- A2 Evaluation of Precision Performance of quantative mea- surement methods; Aproved Guidline second edition[S]. Wayne PA:NCCLS, 2004.
  • 5Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures[S]. Wayne PA:EP-6A, NCCLS, 2004.
  • 6Clinic and Laboratory Strandards Institute. Interference testing in clinical chemistry; Approved Guideline-Second Edition(EP7-A2)[S]. Wayne, PA:CLSI, 2005.
  • 7National Committee for Clinical Laboratory Standsrds EP9- A2. Method comparison and bias estimation using patient samples Approved Guideline[S]. Wayne PA:NCCLS, 2002.
  • 8Ren X S,Yin M H,Zhang X,et al.Tumor-suppressive micro RNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells[J].Cancer Lett,2014,344(2):195-203.
  • 9Yang S,Li Y,Gao J,et al.Micro RNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1[J].Oncogene,2013,32(36):4294-303.
  • 10解晶,喻长法,戴卫峰.白细胞介素-6、降钙素原和C-反应蛋白联合检测在新生儿败血症早期诊断中的价值[J].中华医院感染学杂志,2010,20(22):3628-3629. 被引量:44

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部